![]() |
市場調査レポート
商品コード
1634169
電気外科用デバイスの世界市場 - 2025年~2033年Global Electrosurgical Devices Market - 2025 - 2033 |
||||||
カスタマイズ可能
適宜更新あり
|
電気外科用デバイスの世界市場 - 2025年~2033年 |
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
|
世界の電気外科用デバイス市場は、2023年に62億7,000万米ドルに達し、2033年には91億米ドルに達し、予測期間2025年~2033年にはCAGR 3.7%で成長すると予測されています。
電気手術ユニットは、ボビーとも呼ばれ、切開、乾燥による組織破壊、血液凝固による出血抑制に使用される手術器具です。高出力ジェネレーターを使用して、プローブと手術部位の間に高周波スパークを発生させ、局所的な加熱と組織損傷を引き起こします。ジェネレーターは2つのモードで作動する:アクティブ電極が部位に電流を集中させるモノポーラと、両方の電極が手術部位に位置するバイポーラです。
促進要因と抑制要因
技術進歩の進展
技術の進歩は世界の電気外科用デバイス市場を大きく形成し、手術の精度と安全性を高めています。これには、低侵襲技術、ロボット支援システム、高度なエネルギーベースのモダリティなどが含まれます。これらの進歩は、ヘルスケアプロバイダーが回復時間や合併症を減らし、より良い患者予後を達成するのに役立っています。インテリジェントシステムとデータ解析の統合により、機器の機能性が向上しました。技術の進化に伴い、電気外科用デバイスは様々な医療分野で採用され、市場の成長に寄与しています。
例えば、2024年8月、オリンパスはPowerSealシーラー/ディバイダーのポートフォリオに、PowerSeal Curved Jaw, double-action(SJDA)とPowerSeal Curved Jaw, single-action(CJSA)の2つの新しいデザインのジョーを発表しました。これらの器具は、手術中の剥離、把持、シーリングの手技をサポートし、手技の効率と快適性を促進します。オリンパスは、PowerSealのデザインは、顎の力やシール能力を損なうことなく、顎を閉じるために必要なスクイーズ力が他社製品よりも少なくて済むと主張しています。これらの使い捨て器具は、腹腔鏡手術および開腹手術で使用できます。
器具の高コスト
世界の電気外科用デバイス市場は、先進技術のコストが高いという課題に直面しており、中低所得地域のヘルスケア施設にとっては大きな障壁となっています。こうしたコストは、専門的なトレーニングや技術的な専門知識の必要性と相まって、最先端機器へのアクセスを制限しかねないです。手術成績や効率を向上させる可能性があるにもかかわらず、これらの機器のコストが高いことが、その普及を妨げている可能性があります。
例えば、電気外科用デバイスは、米国ではCovidien、Ellman、Erbeなどの有名ブランドで、5,000ドルから15,000ドルの幅があります。米国以外では、Conmed社やSometech社などが有名です。新品やデモ機は、再生品や中古品よりも高価です。新品はメーカー保証付きで未使用、デモ機は展示モデルです。再生機は改良が施されたもので、メーカーの施設や民間の修理工場で行うことができます。
The global electrosurgical devices market reached US$ 6.27 billion in 2023 and is expected to reach US$ 9.10 billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.
The electrosurgical unit, also known as the Bovie, is a surgical tool used to incise, destroy tissue through desiccation, and control bleeding by coagulating blood. It uses a high-powered generator to produce a radiofrequency spark between a probe and the surgical site, causing localized heating and tissue damage. The generator operates in two modes: monopolar, where an active electrode concentrates current to the site, and bipolar, where both electrodes are located at the surgical site.
Market Dynamics: Drivers & Restraints
Rise in Technological Advancements
Technological advancements have significantly shaped the global electrosurgical devices market, enhancing precision and safety in procedures. This includes minimally invasive techniques, robotic-assisted systems, and advanced energy-based modalities. These advancements help healthcare providers achieve better patient outcomes with reduced recovery times and complications. The integration of intelligent systems and data analytics has improved device functionality. As technology evolves, electrosurgical devices are adopted across various medical disciplines, contributing to the market's growth.
For instance, in August 2024, Olympus has introduced two new jaw designs in its PowerSeal sealer/divider portfolio: the PowerSeal Curved Jaw, double-action (SJDA) and PowerSeal Curved Jaw, single-action (CJSA). These devices support dissection, grasping, and sealing techniques during surgery, promoting procedural efficiency and comfort. Olympus claims that the PowerSeal design requires less squeeze force than competitor instruments to close the jaws, without compromising jaw force or sealing capability. These single-use devices can be used in laparoscopic and open surgery.
High Cost of the Devices
The global electrosurgical devices market faces challenges due to the high cost of advanced technologies, a significant barrier for healthcare facilities in low- and middle-income regions. These costs, coupled with the need for specialized training and technical expertise, can limit access to state-of-the-art equipment. Despite the potential to improve surgical outcomes and efficiency, the high cost of these devices may hinder their widespread adoption.
For instance, Electrosurgical devices can range from $5000 to $15,000 USD, with well-known brands like Covidien, Ellman, and Erbe in the US. Top-selling brands outside the US include Conmed and Sometech. New and demo machines are more expensive than refurbished or used ones. New machines have a manufacturer's warranty and are never used, while demo machines are exhibition models. Refurbished machines have undergone improvements and can be done at the manufacturer's facilities or private repair shops
The global electrosurgical devices market is segmented based on product type, application, end user and region.
Electrosurgical Instruments segment is expected to dominate the Electrosurgical Devices market share
The electrosurgical instruments segment holds a major portion of the electrosurgical devices market share and is expected to continue to hold a significant portion of the electrosurgical devices market share during the forecast period.
Electrosurgical instruments, including electrodes, forceps, scissors, and probes, are crucial for precision and minimal tissue damage in various surgical procedures. They are versatile and used in general surgery, gynecology, urology, and orthopedics. Innovations in design, like non-stick coatings and ergonomics, enhance their effectiveness and safety. As demand for minimally invasive procedures increases, the adoption of advanced electrosurgical instruments is expected to drive market expansion, meeting healthcare providers' needs for reliable and efficient surgical tools.
For instance, in January 2023, Cook Medical has introduced a new, streamlined portfolio of urological bipolar electrodes in the U.S., focusing on the most frequently used products for bladder and prostate procedures. The portfolio includes seven products, six of which are specifically designed for transurethral resection, ablation, and soft tissue removal of the prostate and bladder, and where hemostasis is required. The streamlined portfolio is designed to meet the needs of urologists in the field.
General Surgery segment is the fastest-growing segment in Electrosurgical Devices market share
The general surgery segment is the fastest-growing segment in the electrosurgical devices market share and is expected to hold the market share over the forecast period.
The global electrosurgical devices market is primarily driven by general surgery, which uses these tools for cutting, coagulating, and tissue ablation. These devices offer precision and efficiency, reducing recovery time, blood loss, and complications. As conditions like hernias, appendicitis, and gastrointestinal disorders increase, the demand for electrosurgical devices in general surgery is expected to grow. Advancements in electrosurgical technologies further enhance their application in general surgery, solidifying their critical role in this market segment.
For instance, in 2023, as per NCBI study in the US found that 1 in 9 US households had undergone at least one surgical procedure in the past year, with the highest prevalence among those 65 and older and Medicare beneficiaries, with approximately 1 in 5 reporting such procedures.
North America holds a substantial position in the electrosurgical devices market and is expected to hold most of the market share due to significant investments in medical technologies, and high prevalence of chronic diseases. The region's strong base of leading medical device manufacturers and research institutions drives innovation in electrosurgical technologies. Government initiatives like favorable reimbursement policies and funding for medical advancements contribute to market growth. The widespread adoption of minimally invasive surgical procedures and skilled healthcare professionals further enhance the use of electrosurgical devices.
For instance, in June 2023, Olympus Corporation has announced the availability of its latest electrosurgical generator, the ESG-410, for treating bladder cancer and enlarged prostate. This next-generation generator offers efficiencies in treating NMIBC (non-muscle-invasive bladder cancer) and BPH (enlarged prostate), using various resection loops, band electrodes, and vaporization buttons and needles. The generator supports options and efficiencies in the treatment of these conditions.
Europe is growing at the fastest pace in the Electrosurgical Devices market
Europe holds the fastest pace in the electrosurgical devices market and is expected to hold most of the market share due to established healthcare system and robust regulatory frameworks. The region's focus on improving surgical outcomes and patient safety has led to widespread adoption of advanced electrosurgical technologies. The growing aging population and increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular conditions increase the demand for surgical procedures. Europe's leading medical device manufacturers and research organizations contribute to technological advancements and product development. Government initiatives, reimbursement policies, training programs, and collaborations between healthcare providers and manufacturers further drive market growth.
For instance, in November 2024, Halma PLC has acquired Lamidey Noury Medical for EUR50 Billion, aiming to expand its Healthcare sector. The Paris-based electrosurgical device firm, which is used in urology, gynaecology, and general surgery, is a minimally invasive option used in over 60 countries. The acquisition is funded by existing lending facilities. LNM generated EUR13.6 billion in revenue from the 12 months to October, meeting Halma's target range of 19% to 23%.
The major global players in the electrosurgical devices market include Stryker Corporation, Boston Scientific Corporation, Symmetry Surgical Inc, CONMED Corporation, Medtronic Plc, Ethicon (Johnson and Johnson), B. Braun SE, Smith+Nephew, Olympus Corporation, Abbott Laboratories, OTTek, Dalent Medical, MMI, EGDe Surgical and among others.
The global electrosurgical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE